← Open Payments lookup

SUMBUL ISLAM: Open Payments

NPI 1992898860 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$667 in 44 payments from 13 companies in 2025. Trend: 2023 $724 · 2024 $938 · 2025 $667

Food & beverage: $667
CompanyPaymentsAmount
ABBVIE INC.11$149
Novo Nordisk Inc6$106
GlaxoSmithKline, LLC.5$96
PFIZER INC.3$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$51
Phathom Pharmaceuticals, Inc.7$48
Amgen Inc.2$36
AstraZeneca Pharmaceuticals LP2$29
Corcept Therapeutics1$24
Abbott Laboratories1$24

Products named: VRAYLAR, TRELEGY ELLIPTA, Ozempic, CAPLYTA, VOQUEZNA, AIRSUPRA, LINZESS, ELIQUIS.

Industry payments across TX — which companies pay providers there.